Advertisement

Reactions Weekly

, Volume 1605, Issue 1, pp 140–140 | Cite as

Olmutinib

Acquired C797S mutation leading to drug resistance: case report
Case report
  • 30 Downloads

Reference

  1. Song H-N, et al. Acquired C797S mutation upon treatment with a T790M-specific third-generation EGFR inhibitor (HM61713) in non-small cell lung cancer. Journal of Thoracic Oncology 11: e45-e47, No. 4, Apr 2016. Available from: URL: http://doi.org/10.1016/j.jtho.2015.12.093 - South KoreaCrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Personalised recommendations